Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance. [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial investigates how alpha-to-beta cell communication may adapt insulin secretion to insulin resistance in diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: David D'Alessio, M.D. | Conditions: Diabetes (DM) | Phase 1 | Status: RECRUITING